Jane Street’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Jane Street’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,080	Closed	-$21K	–	11393
2021 Q4	$21K	Buy	+1,080	New	+$30.6K	﹤0.01%	9786
2021 Q2	–	Sell	-905	Closed	-$92K	–	10714
2021 Q1	$92K	Buy	+905	New	+$77.9K	﹤0.01%	8673
2019 Q4	–	Sell	-22	Closed	-$4K	–	5983
2019 Q3	$4K	Buy	+22	New	+$5.27K	﹤0.01%	4982
2018 Q2	–	Sell	-6	Closed	-$22K	–	5808
2018 Q1	$22K	Buy	+6	New	+$17.8K	﹤0.01%	4713

Other funds holding TMBR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Jane Street's TMBR Position: Q1 2022 in Review

Jane Street sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2022, closing a stake of 1,080 shares — an estimated $21K sold.

Jane Street first reported a position in TMBR in Q1 2018 and held it in 4 quarters. The position peaked at $92K in Q1 2021. 15 funds tracked by Wall St. Rank hold TMBR as of Q1 2022.

Jane Street reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Jane Street sold 1,080 Timber Pharmaceuticals, Inc. shares in Q1 2022, an estimated $21K.
Jane Street first reported a position in Timber Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
Jane Street's Timber Pharmaceuticals, Inc. position peaked at $92K in Q1 2021.
15 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.